EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

PURPOSE: The EML4-ALK fusion gene has been detected in ~7% of Japanese non-small cell lung cancers (NSCLC). We determined the frequency of EML4-ALK in Caucasian NSCLCs and in NSCLC cell lines. We also determined whether TAE684, a specific ALK kinase inhibitor, would inhibit the growth of EML4-ALK co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Koivunen, Jussi P., Mermel, Craig, Zejnullahu, Kreshnik, Murphy, Carly, Lifshits, Eugene, Holmes, Alison J., Choi, Hwan Geun, Kim, Jhingook, Chiang, Derek, Thomas, Roman, Lee, Jinseon, Richards, William G., Sugarbaker, David J., Ducko, Christopher, Lindeman, Neal, Marcoux, J. Paul, Engelman, Jeffrey A., Gray, Nathanael S., Lee, Charles, Meyerson, Matthew, Jänne, Pasi A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3025451/
https://ncbi.nlm.nih.gov/pubmed/18594010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0168
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares